Overview

A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen) 200 mg/5 ml Oral Suspension

Status:
COMPLETED
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
Purpose of the study is to compare three different formulations of Ibuprofen oral suspension (liquid taken by mouth) to see if there are any differences in how much of the active substance and how quickly it was taken up by by the body, broken down, and how quickly it was removed from the body.
Phase:
PHASE1
Details
Lead Sponsor:
Berlin-Chemie AG Menarini Group